Question 1

What is the catalog number for 7-O-Acetylintermedine N-oxide?

Accepted Answer

The catalog number for 7-O-Acetylintermedine N-oxide is M32393.

Question 2

What sizes are available for 7-O-Acetylintermedine N-oxide?

Accepted Answer

7-O-Acetylintermedine N-oxide is available in the following size(s): 100 mg, 50 mg, 500 mg, Inquire, 5 mg.

Question 3

How many pack sizes does 7-O-Acetylintermedine N-oxide come in?

Accepted Answer

7-O-Acetylintermedine N-oxide is available in 5 different pack sizes.

Question 4

Is 7-O-Acetylintermedine N-oxide in stock?

Accepted Answer

7-O-Acetylintermedine N-oxide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is 7-O-Acetylintermedine N-oxide used for?

Accepted Answer

7-O-Acetylintermedine-N-oxide is a pyrrolizidine alkaloid isolated from Symphytum officinale.

Question 6

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 7

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 8

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

7-O-Acetylintermedine N-oxide

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

AP1S3 (NM_001039569) Human Over-expression Lysate

IgM Immunoglobulin (Cocktail), 0.2mg/mL

NF2 Antibody

NF2 Antibody

NF2 Antibody

Slc27a2 Mouse Gene Knockout Kit (CRISPR)